All Ireland Lymphoedema Guidelines 2022

Introduction

Lymphoedema is a chronic, progressive condition characterized by the accumulation of protein-rich fluid in the tissues, resulting from impairment of the lymphatic system. The All Ireland Lymphoedema Guidelines 2022 aims to provide healthcare professionals across Ireland with evidence-based recommendations for the diagnosis, assessment, and management of this complex condition.

These guidelines have been developed collaboratively by a multidisciplinary team of healthcare professionals with expertise in lymphoedema care, including lymphoedema therapists, oncologists, vascular surgeons, dermatologists, physiotherapists, occupational therapists, and nursing specialists. The development process incorporated current evidence from international guidelines, systematic reviews, and peer-reviewed literature up to 2022.

These guidelines address the entire spectrum of lymphoedema care, from initial presentation through long-term management, with the primary goal of improving patient outcomes and quality of life. The recommendations are categorized based on the strength of evidence and are intended to be adapted to individual patient circumstances and local healthcare resources.

Diagnosis

Accurate and timely diagnosis of lymphoedema is crucial for appropriate management and prevention of complications. The guidelines recommend a systematic approach to diagnosis, incorporating clinical assessment, imaging when indicated, and exclusion of alternative conditions.

Clinical Assessment

Clinical assessment remains the cornerstone of lymphoedema diagnosis. Healthcare professionals should:

• conduct a thorough patient history, including potential risk factors, previous surgeries, infections, and family history of lymphoedema
• Perform a comprehensive physical examination, evaluating both limbs for asymmetry, texture changes, pitting, and other characteristic signs
• Document the onset, progression, and impact of symptoms on daily activities and quality of life
• Assess for associated conditions, including obesity, venous insufficiency, and recurrent infections

Diagnostic Criteria

The guidelines establish the following criteria for lymphoedema diagnosis:

Imaging and Specialized Testing

While clinical assessment is typically sufficient for diagnosis, certain imaging modalities may be indicated in specific circumstances:

• Lymphoscintigraphy is recommended when clinical diagnosis is uncertain or when distinguishing between different types of lymphoedema
• Ultrasound may be useful to assess deep venous thrombosis as an alternative diagnosis and to examine lymph nodes
• CT or MRI imaging may be indicated when malignancy recurrence is suspected or for surgical planning
• Indocyanine green lymphography is emerging as a valuable tool for mapping superficial lymphatic vessels and may be available in specialized centers

Assessment

Comprehensive assessment of lymphoedema extends beyond diagnosis to include detailed characterization of the condition and its impact on the patient. Regular reassessment is recommended to monitor progression and treatment effectiveness.

Limb Volume Measurement

Accurate measurement of limb volume is essential for diagnosis and monitoring treatment response. The guidelines recommend:

• Perimeter measurement using a tape measure at standardized points along the limb
• Water displacement volumetry as the gold standard for research settings
• Segometer or Perometer when available for more objective measures
• Documentation of measurement technique for consistent longitudinal assessment

Skin Assessment

Detailed evaluation of skin changes is crucial as lymphoedema progression is associated with characteristic tissue alterations:

• Documentation of skin texture, thickness, and presence of fibrosis
• Assessment for peau d'orange (orange peel appearance), lymphangiectasia, and papillomatosis
• Evaluation of skin integrity, including evidence of inflammation, infection, or wounds
• Documentation of skin color and temperature changes

Functional Impact Assessment

Lymphoedema can significantly affect patient function and quality of life. The guidelines recommend incorporation of validated assessment tools:

• Lymphoedema Functioning, Disability and Health Questionnaire (Lymph-ICF) or LYMPH-Q upper/lower limb modules
• Range of motion assessment for affected joints
• Strength testing of affected extremities
• Assessment of activities of daily living and occupational limitations

Psychosocial Assessment

Given the substantial psychosocial impact of lymphoedema, the guidelines emphasize:

• Screening for body image concerns, depression, and anxiety
• Assessment of social participation limitations
• Evaluation of available support systems
• Discussion of treatment expectations and goals

Management

The management approach recommended in these guidelines follows the internationally recognized decongestive lymphatic therapy (DLT) framework, adapted for implementation across Irish healthcare settings. Management strategies are stratified based on severity and progression of lymphoedema.

Phase I: Intensive (Decongestive) Treatment

The intensive phase aims for optimal volume reduction and skin condition improvement. Key components include:

• Manual lymphatic drainage (MLD): Gentle massage techniques encouraging lymph flow toward functioning lymphatic territories, performed by trained therapists
• Multilayer compression bandaging: Application of low-stretch bandages in layers to create graduated compression, with specific protocols for limb wrapping
• Exercise programs: Prescribed exercises designed to enhance muscle and joint pump function within the context of compression therapy
• Skin care: Meticulous hygiene, moisturizing, and protection of affected tissues to prevent infection

Phase II: Maintenance and Self-Management

Following achievement of optimal reduction, transition to maintenance therapy focuses on preserving gains and encouraging independence:

• Compression garments: Custom-fitted flat-knit garments with appropriate compression profile (typically 20-30mmHg or higher for established lymphoedema)
• Simplified MLD techniques: Patient or caregiver instruction in simplified lymphatic drainage techniques
• Ongoing exercise programs: Regular, tailored exercise to maintain lymphatic function and general health
• Weight management: Support for achieving and maintaining healthy body weight, as excess adiposity can exacerbate lymphoedema

Management of Complications

The guidelines provide specific recommendations for managing common lymphoedema complications:

• Cellulitis: Prompt recognition, appropriate antibiotic therapy, patient education on prevention and early signs
• Lymphorrhoea: Management strategies including compression, local wound care, and positioning
• Psychological distress: Referral pathways to psychological support services, peer support groups, and counseling
• Fibrosis: Intensive MLD techniques, compression, and consideration of additional therapies including low-level laser and kinesio taping

Surgical Interventions

Surgical options may be considered for selected patients with advanced or refractory lymphoedema:

• Lipectomy for patients with significant adipose deposition in lymphoedematous limbs
• Lymphatic bypass procedures (lymphaticovenular anastomosis) for carefully selected patients
• Vascularized lymph node transfer for certain cases of secondary lymphoedema
• Referral to centers with specialized lymphatic surgery expertise is recommended

Special Populations

The guidelines address specific considerations for lymphoedema management in particular patient groups.

Cancer-Related Lymphoedema

For patients who develop lymphoedema following cancer treatment, the guidelines emphasize:

• Integration of lymphoedema management within oncology follow-up care
• Specific approaches for breast cancer-related upper limb lymphoedema
• Considerations for gynecological, urological, and melanoma-related lymphoedema
• Care coordination between oncology teams and lymphoedema specialists

Primary Lymphoedema

Management considerations for primary lymphoedema include:

• Genetic counseling considerations for hereditary forms
• Age-appropriate treatment approaches for pediatric patients
• Potential benefits of early intervention in progressive forms
• Consideration of associated anomalies (e.g., lymphatic malformations) in treatment planning

Paediatric Lymphoedema

Specific recommendations for the paediatric population include:

• Age-appropriate communication and engagement of children in their management
• Involvement of family and caregivers in treatment and self-management education
• Consideration of developmental impacts, particularly for school attendance and participation
• Coordination with paediatric services for comprehensive care

Implementation Considerations

Successful implementation of these guidelines requires consideration of healthcare system factors and provider education.

Service Delivery Models

The guidelines endorse a tiered approach to service delivery:

• Tier 1: Primary healthcare providers for early identification and basic management
• Tier 2: Community-based lymphoedema services for routine cases
• Tier 3: Specialized lymphoedema centers for complex cases and education

Education and Training

Core education initiatives should include:

• Integration of lymphoedema content in undergraduate health professional curricula
• Specialized training pathways for lymphoedema therapists
• Continuing professional development opportunities for healthcare providers
• Patient education resources and programs

Quality Improvement

Monitoring implementation and outcomes should include:

• Development of key performance indicators for lymphoedema services
• Patient-reported outcome measures integration
• Audit of guideline adherence and outcomes
• Feedback mechanisms for continuous quality improvement

Key References

1. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology. Lymphology. 2020;53(1):3-19.
2. British Lymphology Society. Consensus Document on the Management of Cellulitis in Lymphoedema. London: British Lymphology Society; 2021.
3. Efficacy of manual lymphatic drainage and compression therapy in breast cancer-related lymphoedema: a systematic review. Eur J Cancer Care (Engl). 2022;31(2):e13498.
4. Diagnosis and management of lymphedema. J Clin Oncol. 2020;38(8):864-876.
5. National Institute for Health and Care Excellence (NICE). Lymphoedema: diagnosis and management. NICE Guideline [NG123]. London: NICE; 2021.
6. Oremus M, et al. Quality of life in breast cancer survivors with lymphoedema: a systematic review of questionnaire-based studies. Qual Life Res. 2021;30(7):1839-1851.
7. Surgical treatment of lymphedema: a systematic review of contemporary literature. Ann Surg. 2021;273(2):390-401.